Purchase Short-Term Access

Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study
Fredrick M. Wigley, MD; Robert A. Wise, MD; James R. Seibold, MD; Deborah A. McCloskey, RN; Gregory Kujala, MD; Thomas A. Medsger, MD; Virginia D. Steen, MD; John Varga, MD; Sergio Jimenez, MD; Maureen Mayes, MD; Philip J. Clements, MD; Steven R. Weiner, MD; John Porter, MD; Michael Ellman, MD; Christopher Wise, MD; Lee D. Kaufman, MD; John Williams, MD; William Dole, MD
Annals of Internal Medicine 1994;120:199-206. doi:10.7326/0003-4819-120-3-199402010-00004

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.